Seeing Is Believing

Currently out of the existing stock ratings of Charles Rhyee, 246 are a BUY (75.93%), 75 are a HOLD (23.15%), 3 are a SELL (0.93%).
Analyst Charles Rhyee, currently employed at TD COWEN, carries an average stock price target met ratio of 69.91% that have a potential upside of 32.33% achieved within 270 days. Previously, Charles Rhyee worked at LAKE STREET.
Charles Rhyee’s has documented 654 price targets and ratings displayed on 41 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CRL, Charles River Laboratories at 20-Feb-2026.
Analyst best performing recommendations are on CSLT (CASTLIGHT HEALTH).
The best stock recommendation documented was for CSLT (CASTLIGHT HEALTH) at 8/4/2021. The price target of $1.9 was fulfilled within 1 day with a profit of $0.16 (7.77%) receiving and performance score of 77.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Oct-2017
$215
$40.04 (22.89%)
$187
2 years 6 months 16 days ago
(07-Aug-2023)
14/15 (93.33%)
$28.91 (15.54%)
602
Hold Since 27-May-2022
$190
$15.04 (8.60%)
$176
2 years 6 months 20 days ago
(03-Aug-2023)
8/8 (100%)
$-0.86 (-0.45%)
433
Buy Since 05-Aug-2021
$220
$45.04 (25.74%)
$213
2 years 6 months 20 days ago
(03-Aug-2023)
11/17 (64.71%)
$29.14 (15.27%)
326
Buy Since 07-Jun-2023
$215
$40.04 (22.89%)
$200
2 years 6 months 20 days ago
(03-Aug-2023)
6/8 (75%)
$24.14 (12.65%)
220
Buy Since 08-Feb-2018
$225
$50.04 (28.60%)
$184
2 years 6 months 22 days ago
(01-Aug-2023)
11/12 (91.67%)
$36.39 (19.29%)
557
Which stock is Charles Rhyee is most bullish on?
Which stock is Charles Rhyee is most reserved on?
What Year was the first public recommendation made by Charles Rhyee?